Symptoms and diagnosis of peptic ulcers
Peptic ulcers are open sores that develop inside the lining of the stomach and upper part of your small intestine (called the duodenum). Your stomach is protected by a thick layer of mucus to protect it from digestive juices. WE get ulcers when the protective layer is reduced.
There are two types of peptic ulcer:-
• Gastric ulcers occur in your stomach.
• Duodenal ulcers occur in the upper part of your small intestine.
Peptic ulcers are a common disease and can be a persistent problem. A healed ulcer can reoccur. A peptic ulcer can be caused due a bacterial infection bacterium Helicobacter pylori (H. pylori) and anti-inflammatory drugs. Stress and spicy food do not cause ulcers, though they can aggravate the symptoms.
Symptoms
Symptoms of peptic ulcers can vary, you may or may not have symptoms. Common symptoms of ulcer are:-
• Burning pain in the stomach.
• Feeling full, bloated or belching.
• Intolerance for fatty food.
• Heartburn.
• Nausea
Your symptoms can worsen with an empty stomach. The pain may stop briefly when you have an anti-acid or after eating.
More severe symptoms of peptic ulcer include:-
• Vomiting or vomit that appears red.
• Dark, bloody stool or black stool.
• Breathing problem.
• Appetite changes.
• Unexplained weight loss.
Book a gastroenterologist in Patna if you have any severe symptoms. You should also see the doctor if the over-the-counter anti-acids stop the pain temporarily.
Causes
Peptic ulcers are caused by an imbalance between the digestive fluid in your stomach (hydrochloric acid) and pepsin in your stomach and duodenum due to:-
• Infection with a bacterium called Helicobacter pylori (H. pylori). Researchers are not sure how the bacteria spread. We can transmit it from person to person personal contact or from food and water.
• Using nonsteroidal anti-inflammatory drugs (NSAID) such as Aspirin, ibuprofen, Naproxen, and celecoxib. These medicines can irritate the lining of your stomach and duodenum. Peptic ulcers are more common with the elderly who take pain medication or medication for osteoarthritis.
• A condition called Zollinger-Ellison syndrome causes excessive production of stomach acid. Gastrinoma a tumor of the acid-producing cells increases the production of acid. Smoking, drinking alcohol, untreated stress, and eating spicy food make your ulcers more difficult to treat.
Diagnosis
The best gastroenterologist in Patna will start by looking at your medical history and performing a comprehensive medical examination. They may order the following tests:-
• Upper endoscopy:- the gastroenterologist uses a tube equipped with a camera to probe your upper digestive tract.
• A barium upper gastrointestinal GI X-ray is used to make the ulcer visible.
• Laboratory tests to determine H. pylori bacteria through stool tests or blood tests at home, or breath tests. Doctors consider the breath test to be more accurate than blood tests. If you have the bacteria, your breath sample will contain radioactive carbon in the form of carbon dioxide.
Treatment
The best gastroenterologist in Patna will treat your peptic ulcers by suggesting lifestyle changes, prescribing medication or surgically.
They may prescribe:-
• Antibiotics to kill H.pylori.
• Proton pump inhibitors (PPI) reduces stomach acid by blocking the cells that produce acid. There are some side-effects of the medication.
• Acid blockers to reduce acid production.
• Anti-acids.
• Medication to protect your stomach lining and intestine.
The gastroenterologist near me may perform a simple endoscopy procedure. They may opt to treat the ulcer surgically if there is a hole in the stomach or serious bleeding.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Apple's Competitive Landscape In today's dynamic business environment, a deep-dive analysis of top companies is essential for investors and industry insiders. This examination will focus on Apple (AAPL), alongside its chief rivals in the Technology Hardware, Storage & Peripherals sector. By analyzing crucial financial indicators, market positioning, and...
Continue Reading
Overview of Cegedim's Liquidity Contract Statement This article covers the latest updates on Cegedim’s liquidity contract performance, highlighting significant figures and trends that reflect the company's financial health. Cegedim has established a robust liquidity contract with Rothschild Martin Maurel, aimed at promoting transparency and liquidity in its shares. Key...
Continue Reading
Silexion Therapeutics Moves Forward with SIL204 Silexion Therapeutics Corp. (NASDAQ: SLXN) is celebrating a significant milestone with the completion of crucial toxicology studies for its innovative RNA silencing therapy, SIL204. This groundbreaking therapy, designed to target mutated KRAS oncogenes, has shown no signs of systemic organ toxicity, reinforcing the...
Continue Reading
Emerson Partners with LifeSight for Pension Solutions LifeSight, WTW’s UK defined contribution (DC) master trust, has stepped into a significant role by becoming the full master trust provider for Emerson, the advanced electronics powerhouse. This partnership aims to cover all active, deferred, and drawdown members effectively, ensuring they are well-accommodated in...
Continue Reading
Exciting News from the Alliance for Decision Education The Alliance for Decision Education is thrilled to announce an important addition to its Board of Directors. Howard Marks, a leader in investment management and a well-respected voice in decision-making, has agreed to join the board. As the co-chairman and co-founder of Oaktree Capital Management, Marks brings with...
Continue Reading